Mitroflow DL Post Approval Study- North America
Public ClinicalTrials.gov record NCT02351726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prospective, non-randomized, multicenter post-approval study to collect long term clinical and echographic data on Mitroflow DL patients.
Study identification
- NCT ID
- NCT02351726
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 186 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2015
- Primary completion
- Dec 30, 2019
- Completion
- Dec 30, 2019
- Last update posted
- Feb 19, 2020
2015 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| River City Clinical Research | Jacksonville | Florida | 32207 | — |
| UF Health - Jacksonville | Jacksonville | Florida | 32209 | — |
| Watson Clinic Center for Research | Lakeland | Florida | 33805 | — |
| Suburban Hospital - John Hopkins Medicine | Bethesda | Maryland | 20814 | — |
| Bay Regional Medical Center | Bay City | Michigan | 48708 | — |
| St. John Hospital & Medical Center | Detroit | Michigan | 48236 | — |
| Catholic Medical Center | Manchester | New Hampshire | 03102 | — |
| St. Joseph's Regional Medical Center | Paterson | New Jersey | 07503 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| University of Virginia Medical Center | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02351726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2020 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02351726 live on ClinicalTrials.gov.